Global PD-L1 Biomarker Testing Competitive Landscape Professional Research Report 2025
Research Summary
PD-L1 (Programmed Cell Death Ligand 1) biomarker testing is a diagnostic procedure used in oncology to determine the level of PD-L1 protein expression on the surface of cancer cells. It plays a crucial role in the field of cancer immunotherapy, particularly in the treatment of solid tumors with immune checkpoint inhibitors. The test involves analyzing tissue samples from a patient＇s tumor to assess the presence and degree of PD-L1 expression. The results of PD-L1 biomarker testing help oncologists and clinicians predict the patient＇s potential response to immunotherapies that target the PD-1/PD-L1 pathway. Higher PD-L1 expression is often associated with a better response to these treatments, making it a valuable tool in personalized cancer care by guiding treatment decisions and improving the effectiveness of immunotherapy for patients with certain types of cancer.
According to DIResearch's in-depth investigation and research, the global PD-L1 Biomarker Testing market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of PD-L1 Biomarker Testing include Agilent Technologies, Roche, Merck, Bristol-Myers Squibb, AstraZeneca, Ono Pharmaceutical, Regeneron, Innovent, Hengrui Medicine, Junshi Biosciences etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of PD-L1 Biomarker Testing. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global PD-L1 Biomarker Testing market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the PD-L1 Biomarker Testing market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of PD-L1 Biomarker Testing industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of PD-L1 Biomarker Testing Include:
Agilent Technologies
Roche
Merck
Bristol-Myers Squibb
AstraZeneca
Ono Pharmaceutical
Regeneron
Innovent
Hengrui Medicine
Junshi Biosciences
PD-L1 Biomarker Testing Product Segment Include:
PD-L1 (22C3)
PD-L1(28-8)
PD-L1 (SP142)
PD-L1 (SP263)
Others
PD-L1 Biomarker Testing Product Application Include:
Hospital
Diagnostic Center
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global PD-L1 Biomarker Testing Industry PESTEL Analysis
Chapter 3: Global PD-L1 Biomarker Testing Industry Porter's Five Forces Analysis
Chapter 4: Global PD-L1 Biomarker Testing Major Regional Market Size and Forecast Analysis
Chapter 5: Global PD-L1 Biomarker Testing Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger PD-L1 Biomarker Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe PD-L1 Biomarker Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China PD-L1 Biomarker Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) PD-L1 Biomarker Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America PD-L1 Biomarker Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa PD-L1 Biomarker Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global PD-L1 Biomarker Testing Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 PD-L1 Biomarker Testing Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 PD-L1 Biomarker Testing Product by Type
- 1.2.1 PD-L1 (22C3)
- 1.2.2 PD-L1(28-8)
- 1.2.3 PD-L1 (SP142)
- 1.2.4 PD-L1 (SP263)
- 1.2.5 Others
- 1.3 PD-L1 Biomarker Testing Product by Application
- 1.3.1 Hospital
- 1.3.2 Diagnostic Center
- 1.3.3 Others
- 1.4 Global PD-L1 Biomarker Testing Market Size Analysis (2020-2032)
- 1.5 PD-L1 Biomarker Testing Market Development Status and Trends
- 1.5.1 PD-L1 Biomarker Testing Industry Development Status Analysis
- 1.5.2 PD-L1 Biomarker Testing Industry Development Trends Analysis
- 2 PD-L1 Biomarker Testing Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 PD-L1 Biomarker Testing Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global PD-L1 Biomarker Testing Market Analysis by Regions
- 4.1 PD-L1 Biomarker Testing Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global PD-L1 Biomarker Testing Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global PD-L1 Biomarker Testing Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global PD-L1 Biomarker Testing Revenue and Market Share Forecast by Region (2026-2032)
- 5 Global PD-L1 Biomarker Testing Market Size by Type and Application
- 5.1 Global PD-L1 Biomarker Testing Market Size by Type (2020-2032)
- 5.2 Global PD-L1 Biomarker Testing Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America PD-L1 Biomarker Testing Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America PD-L1 Biomarker Testing Market Size by Type
- 6.4 North America PD-L1 Biomarker Testing Market Size by Application
- 6.5 North America PD-L1 Biomarker Testing Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe PD-L1 Biomarker Testing Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe PD-L1 Biomarker Testing Market Size by Type
- 7.4 Europe PD-L1 Biomarker Testing Market Size by Application
- 7.5 Europe PD-L1 Biomarker Testing Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China PD-L1 Biomarker Testing Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China PD-L1 Biomarker Testing Market Size by Type
- 8.4 China PD-L1 Biomarker Testing Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) PD-L1 Biomarker Testing Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) PD-L1 Biomarker Testing Market Size by Type
- 9.4 APAC (excl. China) PD-L1 Biomarker Testing Market Size by Application
- 9.5 APAC (excl. China) PD-L1 Biomarker Testing Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America PD-L1 Biomarker Testing Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America PD-L1 Biomarker Testing Market Size by Type
- 10.4 Latin America PD-L1 Biomarker Testing Market Size by Application
- 10.5 Latin America PD-L1 Biomarker Testing Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa PD-L1 Biomarker Testing Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa PD-L1 Biomarker Testing Market Size by Type
- 11.4 Middle East & Africa PD-L1 Biomarker Testing Market Size by Application
- 11.5 Middle East & Africa PD-L1 Biomarker Testing Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global PD-L1 Biomarker Testing Market Revenue by Key Manufacturers (2021-2025)
- 12.2 PD-L1 Biomarker Testing Competitive Landscape Analysis and Market Dynamic
- 12.2.1 PD-L1 Biomarker Testing Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Agilent Technologies
- 13.1.1 Agilent Technologies Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Agilent Technologies PD-L1 Biomarker Testing Product Portfolio
- 13.1.3 Agilent Technologies PD-L1 Biomarker Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 Roche
- 13.2.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Roche PD-L1 Biomarker Testing Product Portfolio
- 13.2.3 Roche PD-L1 Biomarker Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Merck
- 13.3.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Merck PD-L1 Biomarker Testing Product Portfolio
- 13.3.3 Merck PD-L1 Biomarker Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Bristol-Myers Squibb
- 13.4.1 Bristol-Myers Squibb Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Bristol-Myers Squibb PD-L1 Biomarker Testing Product Portfolio
- 13.4.3 Bristol-Myers Squibb PD-L1 Biomarker Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 AstraZeneca
- 13.5.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 AstraZeneca PD-L1 Biomarker Testing Product Portfolio
- 13.5.3 AstraZeneca PD-L1 Biomarker Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Ono Pharmaceutical
- 13.6.1 Ono Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Ono Pharmaceutical PD-L1 Biomarker Testing Product Portfolio
- 13.6.3 Ono Pharmaceutical PD-L1 Biomarker Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Regeneron
- 13.7.1 Regeneron Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Regeneron PD-L1 Biomarker Testing Product Portfolio
- 13.7.3 Regeneron PD-L1 Biomarker Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 Innovent
- 13.8.1 Innovent Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Innovent PD-L1 Biomarker Testing Product Portfolio
- 13.8.3 Innovent PD-L1 Biomarker Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 Hengrui Medicine
- 13.9.1 Hengrui Medicine Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Hengrui Medicine PD-L1 Biomarker Testing Product Portfolio
- 13.9.3 Hengrui Medicine PD-L1 Biomarker Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 Junshi Biosciences
- 13.10.1 Junshi Biosciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Junshi Biosciences PD-L1 Biomarker Testing Product Portfolio
- 13.10.3 Junshi Biosciences PD-L1 Biomarker Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 PD-L1 Biomarker Testing Industry Chain Analysis
- 14.2 PD-L1 Biomarker Testing Industry Raw Material and Suppliers Analysis
- 14.2.1 PD-L1 Biomarker Testing Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 PD-L1 Biomarker Testing Typical Downstream Customers
- 14.4 PD-L1 Biomarker Testing Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook